Rua Diagnostics .Rua Diagnostics .
Rua Diagnostics .

Rua Diagnostics .

Developing a novel, low-cost, point-of-care diagnostic platform for infectious diseases.

2017Active7558
Advertise here
About
Rua Diagnostics is developing groundbreaking technology using breath analysis with gas chromatography (GC) to enable diagnostic testing for highly prevalent and lethal diseases through a single test. Their investigational BreathScan technology aims to reimagine diagnosis by analyzing breath for conditions like lung cancer, colon cancer, and COVID-19. This technology is currently for investigational use only and not for sale in the US.

Technology stack

detected 2026-05-28
Est. monthly stack spend~$2,070/mo
EmailMicrosoft 365
Stack
Wix
Observability
Sentry
Performance

Company Timeline

Capital network
Open in Market Map editor
Frequently asked

What does Rua Diagnostics . do?

Rua Diagnostics is developing groundbreaking technology using breath analysis with gas chromatography (GC) to enable diagnostic testing for highly prevalent and lethal diseases through a single test. Their investigational BreathScan technology aims to reimagine diagnosis by analyzing breath for conditions like lung cancer, colon cancer, and COVID-19. This technology is currently for investigational use only and not for sale in the US.

How much funding has Rua Diagnostics . raised?

Rua Diagnostics . has raised a total of $1M in funding. The most recent round on record is Seed.

Where is Rua Diagnostics . headquartered?

Rua Diagnostics . is headquartered in Cardiff, United Kingdom.

When was Rua Diagnostics . founded?

Rua Diagnostics . was founded in 2017.

What industry does Rua Diagnostics . operate in?

Rua Diagnostics . operates in MedTech, HealthTech, Diagnostics, Point-of-Care Diagnostics, Infectious Diseases, Biotechnology.

How many employees does Rua Diagnostics . have?

Rua Diagnostics . has approximately 7558 people on record.